Scientist Speaks in Rapid City on Stem Cell Research
Page 1 Page 2
Since then, dozens of successful therapies have been derived from adult stem cell research (the number is 73 or more), while there has not been a single successful treatment in humans from ESCR. Ailments treated with adult stem cell therapy include diabetes, heart tissue regeneration, bone tissue, cartilage, a trachea, sickle cell anemia, certain types of paralysis, and more.
Prentice said some 2,000 ongoing or finished clinical trials for various diseases treated with adult stem cells can be found at Clinicaltrials.gov.
Stem Cell Research Facts also shows real-life stories of people who have been successfully treated for various symptoms and injuries.
During an interview before the luncheon, Dr. Prentice said that sometimes people claim that embryonic stem cell research “just needs more time” to show results, but this argument doesn’t hold up. Prentice said that research has been privately funded all along for years, despite the now-repealed ban on taxpayer funding for ESCR. President George W. Bush also allowed research on several specific lines of human embryos before President Barack Obama more fully lifted the ban earlier this year.
When asked about claims that some scientists have managed to extract embryonic stem cells from human embryos without destroying the embryos, Prentice said that while some scientists such as Dr. Richard Lanza and Dr. Young Chung have had some limited success in removing ESC from mice without destroying the embryos, it has not been done in human beings, and the success rate in mice is around 10 to 20 percent or less.
I also asked Dr. Prentice about the extraction of genetic material from human embryos often conducted at IVF clinics to check for genetic diseases. He said, “The cells extracted by ‘embryo biopsy’ for genetic tests are taken several days before ESC form normally in the embryo. But again, that extraction damages many embryos, so I wouldn’t call that a successful or ethical way to obtain ESC.”
So why are some in the scientific community so ardently supportive of ESCR when there are so many difficulties involved and so many successes already achieved with adult stem cells?
“Many scientists are not focused on helping patients, but rather on grant dollars, intellectual curiosity, and a race to be the ‘first’ to accomplish some experiment,” replied Prentice.
Dr. David Prentice is Senior Fellow for Life Sciences at Family Research Council. Up to July 2004 he had spent almost 20 years as Professor of Life Sciences, Indiana State University, and Adjunct Professor of Medical and Molecular Genetics, Indiana University School of Medicine.
He received his Ph.D. in Biochemistry from the University of Kansas, and was at Los Alamos National Laboratory and the University of Texas Medical School-Houston before joining Indiana State University, where he served as Acting Associate Dean of Arts and Sciences, Assistant Chair of Life Sciences, and was recognized with the University’s Distinguished Teaching Award and Distinguished Service Award.
Dr. Prentice is an internationally-recognized expert on stem cells and cloning, and has testified before the U.S. Congress, numerous state legislatures, the U.S. National Academy of Sciences, the President’s Council on Bioethics, European Parliament, British Parliament, Canadian Parliament, Australian Parliament, German Bundestag, French Senate, Swedish Parliament, the Vatican, and the United Nations.
Note: Reader comments are reviewed before publishing, and only salient comments that add to the topic will be published. Profanity is absolutely not allowed and will be summarily deleted. Spam, copied statements and other material not comprised of the reader’s own opinion will also be deleted.
Page 1 Page 2
Pages: 1 2





